hypoglycaemic agent

Also found in: Thesaurus.
Related to hypoglycaemic agent: hypoglycemic agent
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hypoglycaemic agent - any of various agents that decrease the level of glucose in the blood and are used in the treatment of diabetes mellitus
Orinase, tolbutamide - sulfonylurea; an oral antidiabetic drug (trade name Orinase) used in the treatment of adult-onset diabetes mellitus
insulin - hormone secreted by the isles of Langerhans in the pancreas; regulates storage of glycogen in the liver and accelerates oxidation of sugar in cells
agent - a substance that exerts some force or effect
References in periodicals archive ?
Soewondo et al3 performed a multicenter, prospective study to evaluate the efficacy and safety of using biphasic insulin aspart 30 (BIAsp 30) during Ramadan as monotherapy, or in combination with an oral hypoglycaemic agent, in persons with type 2 diabetes.
The partnership will enhance access to this novel oral hypoglycaemic agent by leveraging the huge marketing network of NeoBiocon and distribution network of NMC Healthcare.
Glyburide is a second generation sulfonyl urea oral hypoglycaemic agent (OHA).
As compared to most of the previous reports, our case study illustrates that even patients without a history of diabetes or oral hypoglycaemic agent use, can manifest this life-threatening side-effect.
Type of diabetes was recorded as treated with diet alone, oral hypoglycaemic agent treated, or insulin treated.
Madam, Metformin is a biguanide oral hypoglycaemic agent approved as first line therapy for type 2 diabetes mellitus.
In Cwm Taf Health Board, the error rate for patients who were treated with oral hypoglycaemic agents, to control their blood sugar levels, was 60% and the insulin error rate ranged from 23% at the Royal Glamorgan Hospital to 64% at Prince Charles Hospital.
Jamal said during five days of Hajj it is difficult to carry Insulin and if the patient is taking combination of Insulin and Oral hypoglycaemic agents, the dose of Insulin can be omitted and dose of Oral agents can be increased.
The 4-T study was designed to answer this question--it compared the initiation of insulin as additive therapy with oral hypoglycaemic agents using a basal, biphasic or prandial regimen.
Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus.